How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy

JAMA Oncol. 2015 Jul;1(4):421-2. doi: 10.1001/jamaoncol.2015.0667.

Authors

Michael D Farwell¹, Amy S Clark², David A Mankoff¹

Affiliations

¹ Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Perelman School of Medicine of the University of Pennsylvania, Philadelphia.
² Department of Medicine, Division of Hematology/Oncology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia.

PMID: 26181243
DOI: 10.1001/jamaoncol.2015.0667

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Biomarkers, Tumor / antagonists & inhibitors*
Biomarkers, Tumor / genetics
Biomarkers, Tumor / metabolism
Clinical Trials as Topic / methods*
Decision Support Techniques
Diagnostic Imaging / methods*
Humans
Molecular Targeted Therapy*
Neoplasms / diagnosis*
Neoplasms / drug therapy*
Neoplasms / genetics
Neoplasms / metabolism
Patient Selection
Precision Medicine*
Predictive Value of Tests
Research Design

Substances

Biomarkers, Tumor